Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PTE

PolarityTE (PTE) Stock Price, News & Analysis

PolarityTE logo

About PolarityTE Stock (NASDAQ:PTE)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.20
$0.57
52-Week Range
N/A
Volume
8.50 million shs
Average Volume
249,591 shs
Market Capitalization
$1.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PolarityTE and its competitors with MarketBeat's FREE daily newsletter.

PTE Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.
Regenetp Inc RGTPQ
RegenETP, Inc. (NJT.SG)
PolarityTE Stock (NASDAQ:PTE), Dividends
See More Headlines

PTE Stock Analysis - Frequently Asked Questions

PolarityTE, Inc. (NASDAQ:PTE) posted its quarterly earnings data on Wednesday, November, 10th. The company reported ($2.25) earnings per share for the quarter, topping the consensus estimate of ($3.00) by $0.75. The company earned $1.12 million during the quarter, compared to the consensus estimate of $0.97 million.

PolarityTE shares reverse split on the morning of Tuesday, May 17th 2022.The 1-25 reverse split was announced on Tuesday, May 17th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 17th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that PolarityTE investors own include Bionano Genomics (BNGO), Acasti Pharma (ACST), T2 Biosystems (TTOO), SNDL (SNDL), Zomedica (ZOM), Tonix Pharmaceuticals (TNXP) and Vaxart (VXRT).

Company Calendar

Last Earnings
11/10/2021
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:PTE
CIK
1076682
Employees
42
Year Founded
1986

Profitability

EPS (Trailing Twelve Months)
($3.28)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.83 million
Net Margins
N/A
Pretax Margin
-11,376.71%
Return on Equity
-106.08%
Return on Assets
-76.91%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.11
Quick Ratio
4.11

Sales & Book Value

Annual Sales
$810 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.30 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
7,380,000
Free Float
6,978,000
Market Cap
$1.78 million
Optionable
Optionable
Beta
1.15

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:PTE) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners